Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

Acta Neuropathologica

Volumn 119, Issue 6, 2010, Pages 689-702

  Beach, Thomas G ^a   Adler, Charles H ^b   Sue, Lucia I ^a   Vedders, Linda ^a   Lue, Lih Fen ^a   White III, Charles L ^c   Akiyama, Haru ^d   Caviness, John N ^b   Shill, Holly A ^a   Sabbagh, Marwan N ^a   Walker, Douglas G ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

synuclein; Adrenal gland; Alzheimer's disease; Autonomic nervous system; Dementia with lewy bodies; Enteric nervous system; Esophagus; Gastrointestinal system; Heart; Incidental lewy bodies; Parkinson's disease; Parkinsonism; Peripheral nervous system; Spinal cord; Stomach; Submandibular gland; Sympathetic nervous system

Indexed keywords

ALPHA SYNUCLEIN;

ADRENAL GLAND; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; BRAIN STEM; COLON; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; ENDOCRINE GLAND; ESOPHAGUS; FEMALE; GASTROINTESTINAL TRACT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MYENTERIC PLEXUS; PANCREAS; PARKINSON DISEASE; PERIKARYON; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECTUM; SPINAL CORD; SUBMANDIBULAR GLAND; SYMPATHETIC GANGLION; TISSUE DISTRIBUTION; TISSUE SECTION; TISSUE TYPES; VAGUS NERVE;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; BRAIN; FEMALE; GANGLIA, SYMPATHETIC; GASTROINTESTINAL TRACT; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODY DISEASE; MALE; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM; PHOSPHORYLATION; SPINAL CORD;

EID: 77953021942     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-010-0664-3     Document Type: Article

References (82)

1. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease (1997) The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease Neurobiol Aging 18:S1-S2.
2. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW (2001) Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 57:456-462.
3. Abbott RD, Ross GW, Petrovitch H, Tanner CM, Davis DG, Masaki KH, Launer LJ, Curb JD, White LR (2007) Bowelmovement frequency in late-life and incidental Lewy bodies. Mov Disord.
4. Adler CH (2005) Nonmotor complications in Parkinson's disease. Mov Disord 20(Suppl 11):S23-S29.
5. Adler CH, Hentz JG, Joyce JN, Beach T, Caviness JN (2002) Motor impairment in normal aging, clinically possible Parkinson's disease, and clinically probable Parkinson's disease: longitudinal evaluation of a cohort of prospective brain donors. Parkinsonism Relat Disord 9:103-110.
6. Bagheri H, Damase-Michel C, Lapeyre-Mestre M, Cismondo S, O'Connell D, Senard JM, Rascol O, Montastruc JL (1999) A study of salivary secretion in Parkinson's disease. Clin Neuropharmacol 22:213-215.
7. Bateson MC, Gibberd FB, Wilson RS (1973) Salivary symptoms in Parkinson disease. Arch Neurol 29:274-275.
8. Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL III, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613-634.
9. Beach TG, Sue LI, Walker DG, Roher AE, Lue L, Vedders L, Connor DJ, Sabbagh MN, Rogers J (2008) The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007. Cell Tissue Bank 9:229-245.
10. Beach TG, White CL, Hamilton RL, Duda JE, Iwatsubo T, Dickson DW, Roncaroli F, Buttini M, Hladik CL, Sue LI, Noorigian JV, Adler CH (2008) Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol 116:277-288.
11. Beach TG, White CL III, Hladik CL, Sabbagh MN, Connor DJ, Shill HA, Sue LI, Sasse J, Bachalakuri J, Henry-Watson J, AkiyamaH, Adler CH(2009) Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117:169-174.
12. Bloch A, Probst A, Bissig H, Adams H, Tolnay M (2006) Alphasynuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 32:284-295.
13. Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH (1994) Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb Cortex 4:138-150.
14. Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K (2006) Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord 21:2042-2051.
15. Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213-216.
16. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer- related changes. Acta Neuropathol (Berl) 82:239-259.
17. Braak H, de Vos RA, Bohl J, Del Tredici K (2006) Gastric alphasynuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 396:67-72.
18. Braak H, Del Tredici K (2008) Invited Article: nervous system pathology in sporadic Parkinson disease. Neurology 70:1916-1925.
19. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318:121-134.
20. Braak H, Rub U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517-536.
21. Braak H, Sastre M, Bohl JR, de Vos RA, Del Tredici K (2007) Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 113:421-429.
22. Brait K, Fahn S, Schwarz GA (1973) Sporadic and familial parkinsonism and motor neuron disease. Neurology 23:990-1002.
23. Caviness JN, Smith BE, Clarke SJ, Adler CH, Caselli RJ, Hentz JG, Manfred MS, Muenter D (2002) Motor unit number estimates in idiopathic Parkinson's disease. Parkinsonism Relat Disord 8:161-164.
24. Caviness JN, Smith BE, Stevens JC, Adler CH, Caselli RJ, Reiners CA, Hentz JG, Muenter MD (2000) Motor unit changes in sporadic idiopathic Parkinson's disease. Mov Disord 15:238-243.
25. Christensen J, Stiles MJ, Rick GA, Sutherland J (1984) Comparative anatomy of the myenteric plexus of the distal colon in eight mammals. Gastroenterology 86:706-713.
26. Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A, Kretzschmar H, Hengerer B, Kostka M (2007) Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci 27:9220-9232.
27. Danzer KM, Krebs SK, Wolff M, Birk G, Hengerer B (2009) Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J Neurochem 111:192-203.
28. Del Tredici K, Rub U, de Vos RA, Bohl JR, Braak H (2002) Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413-426.
29. den Hartog Jager WA, Bethlem J (1960) The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 23:283-290.
30. Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 106:13010-13015.
31. Duda JE, Giasson BI, Mabon ME, Lee VM, Trojanowski JQ (2002) Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 52:205-210.
32. Edwards LL, Quigley EM, Harned RK, Hofman R, Pfeiffer RF (1994) Characterization of swallowing and defecation in Parkinson's disease. Am J Gastroenterol 89:15-25.
33. Fujishiro H, Tsuboi Y, Lin WL, Uchikado H, Dickson DW (2008) Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies. Acta Neuropathol 116:17-24.
34. Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160-164.
35. Fumimura Y, Ikemura M, Saito Y, Sengoku R, Kanemaru K, Sawabe M, Arai T, Ito G, Iwatsubo T, Fukayama M, Mizusawa H, Murayama S (2007) Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease. J Neuropathol Exp Neurol 66:354-362.
36. Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33-39.
37. Giasson BI, Duda JE, Forman MS, Lee VM, Trojanowski JQ (2001) Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neurons. Exp Neurol 172:354-362.
38. Hawkes CH, Del Tredici K, Braak H (2007) Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33:599-614.
39. Hishikawa N, Hashizume Y, Hirayama M, Imamura K, Washimi Y, Koike Y, Mabuchi C, Yoshida M, Sobue G (2000) Brainstemtype Lewy body disease presenting with progressive autonomic failure and lethargy. Clin Auton Res 10:139-143.
40. Hishikawa N, Hashizume Y, Yoshida M, Sobue G (2003) Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathol 105:341-350.
41. Hladik CL, White CL (2003) Comparison of digestive enzyme and formic acid pretreatment for optimal immunohistochemical demonstration of alpha-synuclein-immunoreactive cerebral cortical Lewy neurites. J Neuropathol Exp Neurol 62:554.
42. Hopkins DA, Bieger D, de Vente J, Steinbusch WM (1996) Vagal efferent projections: viscerotopy, neurochemistry and effects of vagotomy. Prog Brain Res 107:79-96.
43. Ikemura M, Saito Y, Sengoku R, Sakiyama Y, Hatsuta H, Kanemaru K, Sawabe M, Arai T, Ito G, Iwatsubo T, Fukayama M, Murayama S (2008) Lewy body pathology involves cutaneous nerves. J Neuropathol Exp Neurol 67:945-953.
44. Iseki E, Marui W, Kosaka K, Akiyama H, Ueda K, Iwatsubo T (1998) Degenerative terminals of the perforant pathway are human alpha-synuclein- immunoreactive in the hippocampus of patients with diffuse Lewy body disease. Neurosci Lett 258:81-84.
45. Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H, Satoh A, Seto M, Tsujihata M, Takahashi H (1999) Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 52:1269-1271.
46. Jellinger KA (2004) Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm 111:1219-1235.
47. Kaufmann H, Nahm K, Purohit D, Wolfe D (2004) Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 63:1093-1095.
48. Klos KJ, Ahlskog JE, Josephs KA, Apaydin H, Parisi JE, Boeve BF, DeLucia MW, Dickson DW (2006) Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. Neurology 66:1100-1102.
49. Knowles CH, De GR, Kapur RP, Bruder E, Farrugia G, Geboes K, Gershon MD, Hutson J, Lindberg G, Martin JE, Meier-Ruge WA, Milla PJ, Smith VV, Vandervinden JM, Veress B, Wedel T (2009) Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working Group. Acta Neuropathol 118:271- 301.
50. Koike Y, Takahashi A (1997) Autonomic dysfunction in Parkinson's disease. Eur Neurol 38(Suppl 2):8-12.
51. Kordower JH, Brundin P (2009) Lewy body pathology in longterm fetal nigral transplants: is Parkinson's disease transmitted from one neural system to another? Neuropsychopharmacology 34:254.
52. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14:504-506.
53. Kordower JH, Chu Y, Hauser RA, Olanow CW, Freeman TB (2008) Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov Disord 23:2303-2306.
54. Kupsky WJ, Grimes MM, Sweeting J, Bertsch R, Cote LJ (1987) Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 37:1253-1255.
55. Langston JW (2006) The Parkinson's complex: parkinsonism is just the tip of the iceberg. Ann Neurol 59:591-596.
56. Leopold NA, Kagel MC (1997) Pharyngo-esophageal dysphagia in Parkinson's disease. Dysphagia 12:11-18.
57. Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Bjorklund A, Widner H, Revesz T, Lindvall O, Brundin P (2008) Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 14:501-503.
58. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del ST, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863-1872.
59. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113-1124.
60. Miki Y, Mori F, Wakabayashi K, Kuroda N, Orimo S (2009) Incidental Lewy body disease restricted to the heart and stellate ganglia. Mov Disord 24:2299-2301.
61. Minguez-Castellanos A, Chamorro CE, Escamilla-Sevilla F, Ortega-Moreno A, Rebollo AC, Gomez-Rio M, Concha A, Munoz DG (2007) Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders? A cohort study. Neurology 68:2012-2018.
62. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486.
63. O'Sullivan SS, Holton JL, Massey LA, Williams DR, Revesz T, Lees AJ (2008) Parkinson's disease with Onuf's nucleus involvement mimicking multiple system atrophy. J Neurol Neurosurg Psychiatry 79:232-234.
64. Parkkinen L, Pirttila T, Alafuzoff I (2008) Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 115:399-407.
65. Persson M, Osterberg T, Granerus AK, Karlsson S (1992) Influence of Parkinson's disease on oral health. Acta Odontol Scand 50:37-42.
66. Pfeiffer RF (2003) Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2:107-116.
67. Pinnington LL, Muhiddin KA, Ellis RE, Playford ED (2000) Non-invasive assessment of swallowing and respiration in Parkinson's disease. J Neurol 247:773-777.
68. Proulx M, de Courval FP, Wiseman MA, Panisset M (2005) Salivary production in Parkinson's disease. Mov Disord 20:204- 207.
69. Qualman SJ, Haupt HM, Yang P, Hamilton SR (1984) Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology 87:848-856.
70. Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, Arai T, Nagura H, Yamanouchi H, Hasegawa M, Iwatsubo T, Murayama S (2003) Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 62:644-654.
71. Saito Y, Ruberu NN, Sawabe M, Arai T, Kazama H, Hosoi T, Yamanouchi H, Murayama S (2004) Lewy body-related alphasynucleinopathy in aging. J Neuropathol Exp Neurol 63:742-749.
72. Sica RE, Herskovits E, Aguilera N, Poch G (1973) An electrophysiological investigation of skeletal muscle in Parkinson's disease. J Neurol Sci 18:411-420.
73. Sica RE, Sanz OP (1976) An electrophysiological study of the functional changes in the spinal motoneurones in Parkinson's disease. Electromyogr Clin Neurophysiol 16:409-417.
74. Siddiqui MF, Rast S, Lynn MJ, Auchus AP, Pfeiffer RF (2002) Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. Parkinsonism Relat Disord 8:277-284.
75. Takeda S, Yamazaki K, Miyakawa T, Arai H (1993) Parkinson's disease with involvement of the parasympathetic ganglia. Acta Neuropathol 86:397-398.
76. Tumilasci OR, Cersosimo MG, Belforte JE, Micheli FE, Benarroch EE, Pazo JH (2006) Quantitative study of salivary secretion in Parkinson's disease. Mov Disord 21:660-667.
77. Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685-697.
78. Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ (2007) Patient-reported autonomic symptoms in Parkinson disease. Neurology 69:333-341.
79. Wakabayashi K, Takahashi H (1997) The intermediolateral nucleus and Clarke's column in Parkinson's disease. Acta Neuropathol 94:287-289.
80. Wakabayashi K, Takahashi H, Ohama E, Ikuta F (1990) Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol 79:581-583.
81. Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F (1988) Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol 76:217- 221.
82. Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG (2008) Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. Neurology 70:1042-1048.